Advertisement
help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balducci, L.
Right arrow Articles by Extermann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balducci, L.
Right arrow Articles by Extermann, M.
The Oncologist, Vol. 5, No. 3, 224-237, June 2000
© 2000 AlphaMed Press

Management of Cancer in the Older Person: A Practical Approach

Lodovico Balducci, Martine Extermann

Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Correspondence: Lodovico Balducci, M.D., Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. Telephone 813-979-3822; Fax: 813-972-8468; e-mail: Balducci{at}moffitt.usf.edu Website: http://www.moffitt.nsf.edu

The management of cancer in the older aged person is an increasingly common problem. The questions arising from this problem are: Is the patient going to die with cancer or of cancer? Is the patient able to tolerate the stress of antineoplastic therapy? Is the treatment producing more benefits than harm?

This article explores a practical, albeit evolving, approach to these questions including a multidimensional assessment of the older person and simple pharmacologic interventions that may ameliorate the toxicity of antineoplastic agents. Age may be construed as a progressive loss of stress tolerance, due to decline in functional reserve of multiple organ systems, high prevalence of comorbid conditions, limited socioeconomic support, reduced cognition, and higher prevalence of depression. Aging is highly individualized: chronologic age may not reflect the functional reserve and life expectancy of an individual. A comprehensive geriatric assessment (CGA) best accounts for the diversities in the geriatric population. The advantages of the CGA include:

  1. Recognition of potentially treatable conditions such as depression or malnutrition, that may lessen the tolerance of cancer treatment and be reversed with proper intervention;
  2. Assessment of individual functional reserve;
  3. Gross estimate of individual life expectancy; and
  4. Adoption of a common language to classify older cancer patients.

The CGA allows the practitioner to recognize at least three stages of aging:

  1. People who are functionally independent and without comorbidity, who are candidates for any form of standard cancer treatment, with the possible exception of bone marrow transplant.
  2. People who are frail (dependence in one or more activities of daily living, three or more comorbid conditions, one or more geriatric syndromes), who are a candidate only for palliative treatment; and
  3. People in between, who may benefit from some special pharmacological approach, such as reduction in the initial dose of chemotherapy with subsequent does escalations.

The pharmacological changes of age include decreased renal excretion of drugs and increased susceptibility to myelosuppression, mucositis, cardiotoxicity and neurotoxicity. Based on these findings, the proposal was made that all persons aged 70 and older, treated with cytotoxic chemotherapy of dose intensity comparable to CHOP, receive prophylactic growth factor treatment, and that the hemoglobin of these patients be maintained >=12 gm/dl.

Key Words. Cancer • Elderly • Older person • Geriatric assessment • Pharmacokinetics




This article has been cited by other articles:


Home page
 JCOHome page
M. De Santis, J. Bellmunt, G. Mead, J. M. Kerst, M. Leahy, P. Maroto, I. Skoneczna, S. Marreaud, R. de Wit, and R. Sylvester
Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer "Unfit" for Cisplatin-Based Chemotherapy: Phase II--Results of EORTC Study 30986
J. Clin. Oncol., November 20, 2009; 27(33): 5634 - 5639.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. G. Mohile, Y. Xian, W. Dale, S. G. Fisher, M. Rodin, G. R. Morrow, A. Neugut, and W. Hall
Association of a Cancer Diagnosis With Vulnerability and Frailty in Older Medicare Beneficiaries
J Natl Cancer Inst, September 2, 2009; 101(17): 1206 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Hallek, B. D. Cheson, D. Catovsky, F. Caligaris-Cappio, G. Dighiero, H. Dohner, P. Hillmen, M. J. Keating, E. Montserrat, K. R. Rai, et al.
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Blood, June 15, 2008; 111(12): 5446 - 5456.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
K. M. Field, S. Kosmider, M. Jefford, M. Michael, R. Jennens, M. Green, and P. Gibbs
Chemotherapy Dosing Strategies in the Obese, Elderly, and Thin Patient: Results of a Nationwide Survey
J. Oncol. Pract, May 1, 2008; 4(3): 108 - 113.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
C.-H. Kohne, G. Folprecht, R. M. Goldberg, E. Mitry, and P. Rougier
Chemotherapy in Elderly Patients with Colorectal Cancer
Oncologist, April 1, 2008; 13(4): 390 - 402.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Blijlevens, M. Schwenkglenks, P. Bacon, A. D'Addio, H. Einsele, J. Maertens, D. Niederwieser, W. Rabitsch, A. Roosaar, T. Ruutu, et al.
Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group
J. Clin. Oncol., March 20, 2008; 26(9): 1519 - 1525.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M Kleber, M Cybulla, K Bauchmuller, G Ihorst, B Koch, and M Engelhardt
Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice
Ann. Onc., May 1, 2007; 18(5): 950 - 958.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. Boccia, T. Lillie, D. Tomita, and L. Balducci
The Effectiveness of Darbepoetin Alfa Administered Every 3 Weeks on Hematologic Outcomes and Quality of Life in Older Patients With Chemotherapy-Induced Anemia
Oncologist, May 1, 2007; 12(5): 584 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Bamias, I. Tiliakos, M.-D. Karali, and M. A. Dimopoulos
Systemic chemotherapy in inoperable or metastatic bladder cancer
Ann. Onc., April 1, 2006; 17(4): 553 - 561.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Freyer, A.-C. Braud, P. Chaibi, M. Spielmann, J.-P. Martin, G. Vilela, D. Guerin, and L. Zelek
Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients'
Ann. Onc., February 1, 2006; 17(2): 211 - 216.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Sastre, E. Marcuello, B. Masutti, M. Navarro, S. Gil, A. Anton, A. Abad, E. Aranda, J. Maurel, M. Valladares, et al.
Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study
J. Clin. Oncol., May 20, 2005; 23(15): 3545 - 3551.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Feliu, P. Escudero, F. Llosa, M. Bolanos, J.-M. Vicent, A. Yubero, J.-J. Sanz-Lacalle, R. Lopez, L. Lopez-Gomez, E. Casado, et al.
Capecitabine As First-Line Treatment for Patients Older Than 70 Years With Metastatic Colorectal Cancer: An Oncopaz Cooperative Group Study
J. Clin. Oncol., May 1, 2005; 23(13): 3104 - 3111.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. Bernardi, M. Michieli, M. Rupolo, M. Mazzucato, M. Spina, A. Giacalone, and U. Tirelli
Is high-dose chemotherapy with peripheral stem cell rescue a suitable option for elderly patients affected by aggressive non-Hodgkin's lymphoma?
Ann. Onc., May 1, 2005; 16(5): 837 - 838.
[Full Text] [PDF]

Home page
 Ann OncolHome page
A. Bamias, E. Efstathiou, L. A. Moulopoulos, D. Gika, G. Hamilos, M. P. Zorzou, C. Kakoyiannis, E. Kastritis, G. Bozas, C. Papadimitriou, et al.
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
Ann. Onc., February 1, 2005; 16(2): 307 - 313.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. Talarico, G. Chen, and R. Pazdur
Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug Administration
J. Clin. Oncol., November 15, 2004; 22(22): 4626 - 4631.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
V. Bhatt and A. Saleem
Drug-Induced Neutropenia - Pathophysiology, Clinical Features, and Management
Ann. Clin. Lab. Sci., April 1, 2004; 34(2): 131 - 137.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
M. Airoldi, G. Cortesina, C. Giordano, F. Pedani, A. M. Gabriele, S. Marchionatti, and C. Bumma
Postoperative Adjuvant Chemoradiotherapy in Older Patients With Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, February 1, 2004; 130(2): 161 - 166.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
A. Hurria and M. G. Kris
Management of Lung Cancer in Older Adults
CA Cancer J Clin, November 1, 2003; 53(6): 325 - 341.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Bernardi, I. Milan, M. Balzarotti, M. Spina, A. Santoro, and U. Tirelli
Comprehensive Geriatric Evaluation in Elderly Patients With Lymphoma: Feasibility of a Patient-Tailored Treatment Plan
J. Clin. Oncol., February 15, 2003; 21(4): 754 - 754.
[Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2000 by AlphaMed Press.
Advertisement